Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BuSHIDO: Bucillamine for Remission Maintenance in RA
NCT00716248Phase 4Unknown
- Start
- Jan 2007
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bucillamine in rheumatoid arthritis (RA). Status: unknown.
02
Drugs
bucillamine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00716248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00716248.